Summary
Abbott Laboratories filed an 8-K on April 12, 2005, to report its first-quarter 2005 financial results. The filing primarily serves to furnish a press release detailing these results, which is incorporated by reference. Investors should note that Abbott's management utilizes non-GAAP financial measures, such as earnings excluding one-time charges, to provide a clearer view of ongoing business performance. While these non-GAAP figures are presented to aid investor understanding of operational trends, Abbott emphasizes that they should be considered alongside, and not as a replacement for, traditional GAAP-based financial measures. The press release itself is the primary source of detailed financial information and is attached as Exhibit 99.1 to this 8-K filing.
Key Highlights
- 1Abbott Laboratories announced its first-quarter 2005 results.
- 2The 8-K filing primarily furnished a press release containing these financial results.
- 3Non-GAAP financial measures, such as earnings excluding one-time charges, were used in the report.
- 4Management believes non-GAAP measures offer valuable insights into ongoing business performance.
- 5Investors are advised to consider non-GAAP measures in conjunction with, not as a substitute for, GAAP measures.
- 6The press release (Exhibit 99.1) is the key document for detailed financial information.
- 7Thomas C. Freyman, Executive Vice President, Finance and Chief Financial Officer, signed the filing.